Repurposing of clinically developed drugs for treatment of Middle East Respiratory Coronavirus 1 Infection

[1]  B. Bosch,et al.  Antibodies against MERS Coronavirus in Dromedary Camels, United Arab Emirates, 2003 and 2013 , 2014, Emerging infectious diseases.

[2]  R. Baric,et al.  Rapid generation of a mouse model for Middle East respiratory syndrome , 2014, Proceedings of the National Academy of Sciences.

[3]  Amit Kapoor,et al.  Middle East Respiratory Syndrome Coronavirus Infection in Dromedary Camels in Saudi Arabia , 2014, mBio.

[4]  Z. Memish,et al.  Ribavirin and interferon therapy in patients infected with the Middle East respiratory syndrome coronavirus: an observational study , 2014, International Journal of Infectious Diseases.

[5]  P. Formenty,et al.  State of Knowledge and Data Gaps of Middle East Respiratory Syndrome Coronavirus (MERS-CoV) in Humans , 2013, PLoS currents.

[6]  Amit Kapoor,et al.  Middle East Respiratory Syndrome Coronavirus in Bats, Saudi Arabia , 2013, Emerging infectious diseases.

[7]  K. To,et al.  Broad-spectrum antivirals for the emerging Middle East respiratory syndrome coronavirus , 2013, Journal of Infection.

[8]  V. Corman,et al.  Close Relative of Human Middle East Respiratory Syndrome Coronavirus in Bat, South Africa , 2013, Emerging infectious diseases.

[9]  Victor M Corman,et al.  Middle East respiratory syndrome coronavirus neutralising serum antibodies in dromedary camels: a comparative serological study , 2013, The Lancet Infectious Diseases.

[10]  Yi Shi,et al.  Molecular basis of binding between novel human coronavirus MERS-CoV and its receptor CD26 , 2013, Nature.

[11]  Yong Nyun Kim,et al.  Salinomycin induces cell death via inactivation of Stat3 and downregulation of Skp2 , 2013, Cell Death and Disease.

[12]  Christian Drosten,et al.  Commentary: Middle East Respiratory Syndrome Coronavirus (MERS-CoV): Announcement of the Coronavirus Study Group , 2013, Journal of Virology.

[13]  I. D. Manger,et al.  A Systematic Screen of FDA-Approved Drugs for Inhibitors of Biological Threat Agents , 2013, PloS one.

[14]  Christian Drosten,et al.  Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC , 2013, Nature.

[15]  Chantal Reusken,et al.  Human Betacoronavirus 2c EMC/2012–related Viruses in Bats, Ghana and Europe , 2013, Emerging infectious diseases.

[16]  Kathryn L. Schornberg,et al.  Multiple Cationic Amphiphiles Induce a Niemann-Pick C Phenotype and Inhibit Ebola Virus Entry and Infection , 2013, PloS one.

[17]  S. Africa.,et al.  Close Relative of Human Middle East Respiratory Syndrome Coronavirus in Bat , 2013 .

[18]  Adam Huczyński.  Polyether ionophores-promising bioactive molecules for cancer therapy. , 2012, Bioorganic & medicinal chemistry letters.

[19]  A. Osterhaus,et al.  Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia. , 2012, The New England journal of medicine.

[20]  D. Kalman,et al.  Productive Replication of Ebola Virus Is Regulated by the c-Abl1 Tyrosine Kinase , 2012, Science Translational Medicine.

[21]  D. Kalman,et al.  Variola and Monkeypox Viruses Utilize Conserved Mechanisms of Virion Motility and Release That Depend on Abl and Src Family Tyrosine Kinases , 2010, Journal of Virology.

[22]  Eric S. Lander,et al.  Identification of Selective Inhibitors of Cancer Stem Cells by High-Throughput Screening , 2009, Cell.

[23]  B. Bosch,et al.  Cathepsin L Functionally Cleaves the Severe Acute Respiratory Syndrome Coronavirus Class I Fusion Protein Upstream of Rather than Adjacent to the Fusion Peptide , 2008, Journal of Virology.

[24]  S. Inoue,et al.  Clathrin-Dependent Entry of Severe Acute Respiratory Syndrome Coronavirus into Target Cells Expressing ACE2 with the Cytoplasmic Tail Deleted , 2007, Journal of Virology.

[25]  Peter Loga,et al.  Chlorpromazine in migraine , 2007, Emergency Medicine Journal.

[26]  Ralph Baric,et al.  A Mouse-Adapted SARS-Coronavirus Causes Disease and Mortality in BALB/c Mice , 2007, PLoS pathogens.

[27]  D. Barnard,et al.  Evaluation of Immunomodulators, Interferons and Known in Vitro SARS-CoV Inhibitors for Inhibition of SARS-Cov Replication in BALB/c Mice , 2006, Antiviral chemistry & chemotherapy.

[28]  Jun O. Liu,et al.  A clinical drug library screen identifies astemizole as an antimalarial agent , 2006, Nature chemical biology.

[29]  J. Bergelson,et al.  Virus-Induced Abl and Fyn Kinase Signals Permit Coxsackievirus Entry through Epithelial Tight Junctions , 2006, Cell.

[30]  Grant McFadden.  Gleevec casts a pox on poxviruses , 2005, Nature Medicine.

[31]  M. Ng,et al.  Infectious Entry of West Nile Virus Occurs through a Clathrin-Mediated Endocytic Pathway , 2004, Journal of Virology.

[32]  I. Kurane,et al.  Interference in Japanese encephalitis virus infection of Vero cells by a cationic amphiphilic drug, chlorpromazine. , 2003, The Journal of general virology.

[33]  W. Atwood,et al.  JC Virus Enters Human Glial Cells by Clathrin-Dependent Receptor-Mediated Endocytosis , 2000, Journal of Virology.

[34]  O. Krizanova,et al.  Influence of chlorpromazine on the replication of influenza virus in chick embryo cells. , 1982, Acta virologica.

[35]  P. Cash.  Inhibition of La Crosse virus replication by monensin, monovalent ionophore. , 1982, The Journal of general virology.